Want to see IN:SOLARA full AI Analyst Report?
Solara Active Pharma Sciences Ltd. (SOLARA) Financial Statements
Solara Active Pharma Sciences Ltd. Financial Overview
Solara Active Pharma Sciences Ltd.'s market cap is currently $30.43B. The company's EPS TTM is $7.72; its P/E ratio is 81.94; and it has a dividend yield of 0.45%. Solara Active Pharma Sciences Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 13.69B | $ 12.84B | $ 12.89B | $ 14.27B | $ 12.68B |
| Gross Profit | $ 3.66B | $ 6.57B | $ -1.30B | $ 1.25B | $ 5.60B |
| Operating Income | $ 870.70M | $ 4.46B | $ -3.85B | $ 85.60M | $ -332.80M |
| EBITDA | $ 1.87B | $ 2.06B | $ -2.82B | $ 1.53B | $ 863.30M |
| Net Income | $ -74.10M | $ 5.40M | $ -5.67B | $ -221.70M | $ -581.50M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 533.40M | $ 41.10M | $ 84.40M | $ 87.30M | $ 463.80M |
| Total Assets | $ 23.33B | $ 22.32B | $ 23.51B | $ 28.99B | $ 29.53B |
| Total Debt | $ 6.87B | $ 7.96B | $ 10.12B | $ 10.13B | $ 10.37B |
| Net Debt | $ 6.36B | $ 7.92B | $ 10.03B | $ 10.04B | $ 9.91B |
| Total Liabilities | $ 10.77B | $ 11.35B | $ 14.14B | $ 13.97B | $ 14.18B |
| Stockholders' Equity | $ 12.53B | $ 10.94B | $ 9.34B | $ 15.00B | $ 15.25B |
| Cash Flow | |||||
| Free Cash Flow | $ 88.80M | $ 1.73B | $ 678.10M | $ 449.40M | $ -4.51B |
| Operating Cash Flow | $ 617.00M | $ 2.13B | $ 1.09B | $ 1.56B | $ -2.42B |
| Investing Cash Flow | $ -998.60M | $ -368.30M | $ -35.10M | $ -811.40M | $ -2.43B |
| Financing Cash Flow | $ 386.90M | $ -1.80B | $ -1.06B | $ -1.13B | $ 3.34B |
Currency in INR